Sector Gamma As Lexicon Pharmaceuticals, Inc. Transaction History

Sector Gamma As

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Jul 31, 2019	SELL	$5.35 - $7.11 $2.01 Million - $2.68 Million	-376,502 Closed	0 $0
Q1 2019 May 13, 2019	SELL	$4.36 - $7.94 $2.12 Million - $3.86 Million	-486,100 Reduced 56.35%	376,502 $2.09 Million
Q3 2018 Nov 15, 2018	BUY	$10.32 - $13.06 $3.64 Million - $4.61 Million	353,023 Added 69.28%	862,602 $9.2 Million
Q3 2018 Nov 08, 2018	SELL	$10.32 - $13.06 $3.64 Million - $4.61 Million	-353,023 Reduced 40.93%	509,579 $5.44 Million
Q2 2018 Aug 02, 2018	BUY	$7.8 - $13.69 $62,478 - $109,656	8,010 Added 0.94%	862,602 $10.4 Million
Q1 2018 May 09, 2018	BUY	$7.86 - $11.39 $136,764 - $198,186	17,400 Added 2.08%	854,592 $7.32 Million
Q4 2017 Feb 12, 2018	BUY	$8.77 - $12.28 $874,711 - $1.22 Million	99,739 Added 13.52%	837,192 $8.27 Million
Q3 2017 Nov 07, 2017	BUY	$12.17 - $16.3 $1.4 Million - $1.87 Million	114,798 Added 18.44%	737,453 $9.06 Million
Q2 2017 Aug 14, 2017	BUY	N/A	622,655	622,655 $10.2 Million

141

238M

459K

133K

Ticker LXRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,726,000
Market Cap $134M
Description
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...

Get notified when there are updates to the investment portfolio of Sector Gamma As, based on Form 13F filings with the SEC.

Stay updated on Sector Gamma As with notifications on news.